ZEB2 and acute myeloid leukemia: Similar explorations were performed by Li et al. [40] by using the CRISPR-mediated knockout or the shRNA-mediated knockdown of ZEB2, which induced myeloid differentiation and reduced the cell growth in the AML cell lines of humans in vitro.